GSK1362885

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Diabetes Mellitus, Type 2

Phase 1

A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects

CompletedNCT00823940

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2009-01-13End: 2009-04-27Updated: 2017-07-07

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

CompletedNCT01013766

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2009-08-13End: 2009-11-20Updated: 2017-06-20